Latest Expert Opinions

Signal
Opinion
Expert
BUY
BUY
July 12, 2005
One of the better run banks in the US. Have just taken over MBNA which is one of the largest credit card issuers in North America. This is a growth area which is what banks are looking for. A very logical buy.
One of the better run banks in the US. Have just taken over MBNA which is one of the largest credit card issuers in North America. This is a growth area which is what banks are looking for. A very logical buy.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$45.310
Owned
No
BUY
BUY
July 12, 2005
If you are looking at major chemicals, Dow Chemical (DOW-N) and Lyondell Chemical (LYO-N) would both be good. Lyondell is cheap, good dividend and has growth ahead of it.
If you are looking at major chemicals, Dow Chemical (DOW-N) and Lyondell Chemical (LYO-N) would both be good. Lyondell is cheap, good dividend and has growth ahead of it.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$47.560
Owned
Unknown
BUY
BUY
July 12, 2005
If you are looking at major chemicals, Dow Chemical (DOW-N) and Lyondell Chemical (LYO-N) would both be good. Lyondell is cheap, good dividend and has growth ahead of it. He is looking at Lyondell right now.
If you are looking at major chemicals, Dow Chemical (DOW-N) and Lyondell Chemical (LYO-N) would both be good. Lyondell is cheap, good dividend and has growth ahead of it. He is looking at Lyondell right now.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$28.760
Owned
No
WEAK BUY
WEAK BUY
July 12, 2005
Was a darling stock and fell out of favour because they had a problem with enough bottling capacity in key markets and were also hurt by rising material costs, especially aluminim and plastics. They have addressed their problems with bottling. If you're a long term investor, this might be a good time to be looking at this one.
Cott Corp (BCB-T)
July 12, 2005
Was a darling stock and fell out of favour because they had a problem with enough bottling capacity in key markets and were also hurt by rising material costs, especially aluminim and plastics. They have addressed their problems with bottling. If you're a long term investor, this might be a good time to be looking at this one.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$27.040
Owned
No
DON'T BUY
DON'T BUY
July 12, 2005
Not a good buying opportunity at this level or anywhere near this level. The company is still in disarray with the recent management changes. The business they're in is highly competitive. Not as leading edge as they had been and they're losing market share.
Nortel (NT-T)
July 12, 2005
Not a good buying opportunity at this level or anywhere near this level. The company is still in disarray with the recent management changes. The business they're in is highly competitive. Not as leading edge as they had been and they're losing market share.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$3.280
Owned
No
PAST TOP PICK
PAST TOP PICK
July 12, 2005
(A Top Pick May 17/05. Up 11.5%.) Pleased that it's up, but not sure why. Sold one of its major divisions, took in a lot of cash and haven't announced how they are going to redeploy that.
(A Top Pick May 17/05. Up 11.5%.) Pleased that it's up, but not sure why. Sold one of its major divisions, took in a lot of cash and haven't announced how they are going to redeploy that.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$27.650
Owned
Yes
PAST TOP PICK
PAST TOP PICK
July 12, 2005
(A Top Pick May 17/05. Up 6%.) Most of its patients are Medicare and Medicade people on funding.
Manor Care (HCR-N)
July 12, 2005
(A Top Pick May 17/05. Up 6%.) Most of its patients are Medicare and Medicade people on funding.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$36.540
Owned
Yes